Pharmaceutical sales data from publicly available financial reports or press releases

FDA Approves Nasal Spray for Severe Allergies

Aug 21, 2024, 02:20 AM

The US Food and Drug Administration (FDA) has approved a new nasal spray device for administering epinephrine, the active ingredient in EpiPens, to treat severe allergies. This innovative approach offers an alternative to the traditional needle-based method, providing a potentially life-saving solution for patients who experience severe allergic reactions but are hesitant to use EpiPens. The nasal spray is designed to address both mild and severe allergies, marking a significant advancement in allergy treatment.